BriaCell Therapeutics (BCTX)
Develops HLA-matched cell immunotherapies for metastatic breast cancer and other solid tumors.
$3.57
Pre-market−0.01 (−0.28%)
At close$3.58(−1.38%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Oct '24Dec '24Mar '25Jun '25Oct '25Dec '25Mar '26Jun '26
Reported−$0.07−$32.98−$23.30−$1.64−$10.49−$4.35−$2.58−$0.99
Estimate−$0.52−$0.30−$19.40−$17.60−$12.11−$3.28−$4.84—
Surprise+86.5%−10,893.3%−20.1%+90.7%+13.4%−32.6%+46.7%—
RevenueReportedEstimate
Oct '24Dec '24Mar '25Jun '25Oct '25Dec '25Mar '26Jun '26
Reported————————
Estimate—————$2.1M——
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2026 | — | −$0.99 | — |
| Mar 2026 | −$4.84 | −$2.58 | +46.7% |
| Dec 2025 | −$3.28 | −$4.35 | −32.6% |
| Oct 2025 | −$12.11 | −$10.49 | +13.4% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Jun 2025 | |||
| Mar 2025 | |||
| Dec 2024 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Jun 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Jul 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Apr 2015 | |||
| Jan 2015 | |||
| Oct 2014 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | — | −$0.99 | — | — | — | — | −6.2% |
| Mar 10, 2026 | −$4.84 | −$2.58 | +46.7% | — | — | — | +13.9% |
| Dec 11, 2025 | −$3.28 | −$4.35 | −32.6% | $2.1M | — | — | −7.5% |
| Oct 27, 2025 | −$12.11 | −$10.49 | +13.4% | — | — | — | −0.6% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||||||
| Jun 16, 2025 | |||||||
| Mar 12, 2025 | |||||||
| Dec 16, 2024 | |||||||
| Oct 28, 2024 | |||||||
| Jul 31, 2024 | |||||||
| Jun 14, 2024 | |||||||
| Mar 18, 2024 | |||||||
| Dec 14, 2023 | |||||||
| Oct 25, 2023 | |||||||
| Jul 31, 2023 | |||||||
| Jun 14, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Dec 14, 2022 | |||||||
| Jul 5, 2022 | |||||||
| Jun 13, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Dec 14, 2021 | |||||||
| Oct 29, 2021 | |||||||
| Jul 31, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Jan 11, 2021 | |||||||
| Oct 31, 2020 | |||||||
| Jul 31, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Jan 31, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Jan 31, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Jul 31, 2018 | |||||||
| Jan 31, 2018 | |||||||
| Oct 31, 2017 | |||||||
| Apr 30, 2017 | |||||||
| Jan 31, 2017 | |||||||
| Oct 31, 2016 | |||||||
| Jul 31, 2016 | |||||||
| Jan 31, 2016 | |||||||
| Oct 31, 2015 | |||||||
| Apr 30, 2015 | |||||||
| Jan 31, 2015 | |||||||
| Oct 31, 2014 | |||||||